How did LABU's Momentum indicator behave recently?

The Momentum Indicator moved below the 0 level on July 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LABU as a result. In 91 of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

What does a 3-day price advance indicate for LABU?

Following a +1.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where LABU advanced for three days, in 285 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

LABU

AS OF

Jul 30, 04:59 PM (EDT)

Price

$248.93

Change

+$16.70 (+7.19%)

Net Assets

525.58M

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

+Compare

LABU

ETF ticker: NYSE ARCA

AS OF

Jul 30, 04:59 PM (EDT)

Price

$248.93

Change

+$16.70 (+7.19%)

Net Assets

525.58M

LABU

ETF ticker: NYSE ARCA

PRICE

CHANGE

NET ASSETS

LABU stock forecast, quote, news & analysis

Q: How does the Aroon Indicator reflect on LABU's trend?

The Aroon Indicator entered an Uptrend today. In 190 of 196 cases where LABU Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index")... Show more

Category: #Trading

Get AI intraday signals

LABU

Setup

Daily Signal:

Description

Gain/Loss:

A.I.Advisor

published price charts

Intraday

View AI-Driven Trading for LABU

Interact to see
Advertisement

A.I.Advisor

a Summary for LABU with price predictions

Jul 29, 2026

LABU's RSI Oscillator peaks and leaves overbought zone

The 10-day RSI Oscillator for LABU moved out of overbought territory on July 10, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 instances where the indicator moved out of the overbought zone. In of the 24 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LABU as a result. In of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for LABU turned negative on July 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LABU declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LABU advanced for three days, in of 304 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 196 cases where LABU Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor

published Highlights

Notable companies

The most notable companies in this group are ABBVIE (NYSE:ABBV), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exact Sciences Corp (NASDAQ:EXAS), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR).

Industry description

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index"). The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.

Market Cap

The average market capitalization across the Direxion Daily S&P Biotech Bull 3X ETF ETF is 13.08B. The market cap for tickers in the group ranges from 46.14M to 465.2B. ABBV holds the highest valuation in this group at 465.2B. The lowest valued company is SCLX at 46.14M.

High and low price notable news

The average weekly price growth across all stocks in the Direxion Daily S&P Biotech Bull 3X ETF ETF was 24%. For the same ETF, the average monthly price growth was 124%, and the average quarterly price growth was 217%. INCY experienced the highest price growth at 10%, while CAPR experienced the biggest fall at -65%.

Volume

The average weekly volume growth across all stocks in the Direxion Daily S&P Biotech Bull 3X ETF ETF was 16%. For the same stocks of the ETF, the average monthly volume growth was -34% and the average quarterly volume growth was -46%